Reproductive health experts consider hormonal contraceptives good choices for adolescents because they’re safe and highly effective at preventing pregnancy, but one aspect of their effect on the teenage body remains a mystery – whether and how they modify the developing brain.
Mountainside Medical Center is approved to use Pluvicto™, an FDA-approved, targeted radioligand therapy for treatment of metastatic prostate-specific membrane antigen positive castration-resistant prostate cancer. This makes Mountainside the first in the state to offer treatment using Pluvicto™.
A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.”
In a new ‘Ideas and Opinions,’ authors from Johns Hopkins Bloomberg School of Public Health analyze California’s newly announced effort to manufacture insulin for its residents. The commentary is published in Annals of Internal Medicine.
Stanford University researchers recently conducted a systematic review of studies on cervical radiculopathy, commonly referred to as “pinched nerve,” to determine if steroids are a safe and effective treatment.
Naltrexone was originally used to help treat alcohol and opioid abuse. However, at lose doses, naltrexone has been found to help with chronic pain stemming from various conditions including fibromyalgia, Crohn’s disease, diabetic neuropathy, axial low back pain, rheumatoid arthritis, and complex region pain syndrome.
MD Anderson and Exscientia today announced a strategic collaboration to align the drug development expertise of MD Anderson with the patient-centric AI capabilities of Exscientia to advance new targeted cancer therapies.
Traditional Chinese medicine (TCM) has been around for centuries.
Intranasal (in.) administration has been garnering increasing popularity as a non-invasive approach to deliver drugs directly to the brain.
Researchers at UC Riverside are paving the way for diabetes and cancer patients to forget needles and injections, and instead take pills to manage their conditions.
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
Rutgers scientists among those experts who believe Triethylene glycol (TEG) should become a government approved antiviral
Rutgers research shows how changes in the brain promote drug-seeking behavior and why some insomnia medications may block it
The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution.
A normal process called cell competition, in which healthy tissues eliminate unhealthy cells, could be responsible for cancer relapses in patients months or years after they were declared cancer-free
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients.
New research presented this week at ACR Convergence, the organization's annual meeting, found no significant difference in cancer risk in patients with rheumatic disease & a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus
Research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a novel program that offers rheumatoid arthritis (RA) training to primary care providers in the Navajo Nation, the largest American Indian reservation in the United States.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right